AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older - Reuters
ByAinvest
Saturday, May 31, 2025 12:50 am ET1min read
US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older - Reuters
The U.S. Food and Drug Administration (FDA) has approved Moderna's next-generation COVID-19 vaccine for all individuals aged 65 and older, marking a significant step in the ongoing battle against the pandemic. This approval comes after the FDA tightened its regulatory requirements, indicating a more stringent review process for new vaccines [1].The vaccine, which uses mRNA technology, has also been approved for individuals aged 12 to 64 with at least one or more underlying risk factors, such as diabetes, heart disease, or cancer. This expanded approval aims to protect vulnerable populations who are at higher risk of severe COVID-19 complications [1].
The approval follows a period of intense scrutiny and debate over the necessity and effectiveness of COVID-19 vaccines for various age groups and risk profiles. The Centers for Disease Control and Prevention (CDC) has recently removed COVID-19 vaccinations from the list of recommended vaccines for healthy children and pregnant women, citing insufficient evidence that healthy individuals under 65 would benefit from additional shots [2].
The CDC's new recommendations align with the World Health Organization's (WHO) guidelines, which do not recommend annual shots for healthy individuals under age 50, unless they have not been previously vaccinated against COVID-19. However, the WHO does recommend that pregnant women receive an updated COVID-19 vaccine during each pregnancy [2].
This development is part of a broader trend in public health policy, reflecting a shift towards more targeted and evidence-based approaches to vaccine recommendations. As the pandemic continues to evolve, these decisions will play a crucial role in shaping the future of COVID-19 vaccination strategies.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L2N3S300Z:0-us-fda-approves-moderna-s-next-gen-covid-vaccine-for-adults-65-or-older/
[2] https://www.krtv.com/health/cdc-to-eliminate-covid-19-vaccine-recommendations-for-children-pregnant-women
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet